Table 5.

Fasting glucose, fasting insulin and HOMA IR in three points (before treatment, at the end of treatment and 6 months after treatment), in both groups of participants

	Group II				P value
	N	Mean ± SD	N	Mean ± SD
Fasting glucose (mmol/L)
BT	35	5.35 ± 0.7	35	5.41 ± 0.7	A0.7
ET	35	4.92 ± 0.7	35	5.28 ± 0.8	A0.049*
AT	35	5.19 ± 0.7	35	5.34 ± 0.6	A0.415
Fasting insulin (mmol/L)
BT	31	12.95 ± 11.1	35	11.98 ± 10.7	B0.72
ET	26	9.53 ± 7.6	35	15.15 ± 10.9	A0.032*
AT	25	13.55 ± 10.6	35	10.86 ± 7.4	A0.33
HOMA IR
BT	31	3.12 ± 3.04	35	2.81 ± 2.5	B0.67
ET	26	2.15 ± 2.1	35	3.51 ± 3.4	B0.01*
AT	25	3.19 ± 2.7	35	2.38 ± 1.7	B0.45

Group I (with Atorvastatin), group II (without Atorvastatin); ^a (Student t test); ^b(Mann-Whitney test);

^*p < 0.05; BT-before treatment; ET-end of treatment; AT-after treatment (6 months).